Autopsy report · NCT04408352
RF Ablation of the Trigone for the Treatment of UUI
Cause of deathFunding or business
“for business planning purposes only, and is not related to any safety or performance issues identified during the study”
Life of this trial
- Suspended: paused, and may or may not restart.
- 225 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Hologic, Inc.
- Sponsor type
- Industry
- Conditions
- Urgent Urinary Incontinence
- Interventions
- selective bladder denervation using RF energy
- Participants
- 225 (planned, not actual)
- Sites
- 6
- Countries
- United States
Trials that died the same way
- PRONTO: Artemis in the Removal of Intraventricular Hemorrhage in the Hyper-Acute Phase
“Business decision to focus on other studies. No safety concern.” - A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
“Based on input from regulatory agencies, it is not necessary to conduct this study. An ongoing study was sufficient for regulatory purposes.” - Study of Poziotinib in Japanese Patients With NSCLC
“Business decision, not related to safety.” - Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and Diabetes
“Business Decision; No Safety Or Efficacy Concerns. (See below)” - Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors
“Not related to safety concerns or lack of efficacy”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.